DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings C

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2023 Conference Call.

Related Keywords

United States , Canada , Australia , Canadian , Australian , Scott Kellen , Dietrich Pauls , Rick Pauls , Thomas Flaten , Alex Nowak , Scott Kasner , Nasdaq , Marinus Pharmaceuticals , Nektar Therapeutics , Health Canada , Cubist Pharmaceuticals , Australian Stroke Trials Network , International Stroke Conference , Diamedica Therapeutics Inc , National Institutes Of Health Stroke Scale , Opiant Pharmaceuticals , Canadian Stroke Consortium , Diamedica Therapeutics , Call Transcript March , Medica Therapeutics , Diamedica Therapeutics Full Year , Investor Relations , Cautionary Statement Note , Risk Factors , Chief Executive , Lorianne Masuoka , Chief Medical Officer , Chief Medical , Epygenix Therapeutics , Global Principal Investigator , National Institutes , Health Stroke Scale , Rebekah De Vitry Fries , Vice President , Clinical Operations , Lake Street , Lowest Fertility ,